Empower your patients through early detection
Understanding Health Through Breath
Nanotechnology, chemistry and machine learning converge in the MyBreathPrint® system, advancing the potential for physicians to classify patients quickly throughout their journey. Serving as your copilot, MyBreathPrint can help you accurately diagnose, make more informed decisions, and provide the best treatment options for your patients as possible.
While Vocxi Health has initially developed MyBreathPrint to detect lung cancer, with its one hardware design MyBreathPrint is scalable and, through its machine learning platform, customizable to detect a wide variety of diseases, ailments and health issues.
other cancers
infectious deseases
emergency medicine
Clinical Studies
With its nanosensor array’s parts per billion-level sensitivity and machine learning approach, MyBreathPrint has demonstrated successful early lung cancer detection through three Institutional Review Board-approved human clinical studies. It was proven four times more accurate than other screening approaches in the detection of stage-one lung cancer.
Of the 200 people who have used the device, 100 percent responded positively to its ease of use. The accessibility, accuracy and adaptability of MyBreathPrint have the potential to transform the patient journey and save millions of lives, one patient at a time.
Our Mission Is to Create the Most Accessible and Accurate Breath Sensor to Understand Patient Health As Early As Possible.
The Vocxi Health Value-add
MyBreathPrint through the care pathways
VALUE ADD TO
Very Low-risk Patients
The current care pathway is surveillance wait and see until symptoms arise.
MyBreathPrint: Give the provider additional information at 3-, 6- or 12-month intervals.
PROVIDER: Perform biopsy sooner and catch the cancer sooner.
PAYER: Limiting risk of an unnecessary biopsy with a negative result.
PATIENT: Perform biopsy sooner and catch the cancer sooner.
VALUE ADD TO
Medium-risk Patients
The current care pathway is filled with uncertainty: CT scans, potential biopsy or more surveillance.
MyBreathPrint: It gives the provider an informed path to biopsy or further surveillance months.
PROVIDER: Informed decision about biopsy vs. surveillance.
PAYER: Reduce non-responder drug costs.
PATIENT Avoid debt-burden of expensive treatments if non-responder.
VALUE ADD TO
High-risk Patients
The current care pathway is often an invasive treatment followed by invasive follow-ups.
MyBreathPrint: Disease monitoring can become a noninvasive, simpler post-treatment/drug monitoring solution.
PROVIDER: Informed decision about biopsy vs. surveillance .
PAYER: Reduce non-responder drug costs.
PATIENT: Avoid debt-burden of expensive treatments if non-responder.
The patient journey difference
How MyBreathPrint Transforms Processes and Outcomes
The simple-to-use elegance of the MyBreathPrint system has the potential to serve as the physician’s copilot, helping them improve the patient journey through more accurate diagnosis, more informed decision-making and providing the best treatment solutions possible.
- improved process
-
No lab Needed
With our platform approach, there are no fluids to mix, no extra steps to complicate the patient and clinical staff experience.
no extra space
The handheld device is the size of a deck of cards; easy to handle, easy to use with no analytical laboratory equipment or annual maintenance fees.
immediate
After one minute of breathing, results are delivered within moments so you can quickly know and begin discussions with your patient.
accessible
With its size, mobility, connectivity and contribution to a lower cost of care, MyBreathPrint helps break down healthcare accessibility barriers.
Class 2 device
Just one-minute of breathing is required! Completely non-invasive with no needles, no tissue samples, no radiation exposure!
- improved patient outcome
-
Non-invasive
MyBreathPrint is as noninvasive as breathing — no needles, no swabs, no radiation — promoting patient comfort and care. Accurate
With parts per billion sensitivity, MyBreathPrint can detect VOCs found in breath, and leverage machine learning to generate a BreathPrint.
No Waiting
Knowing whether a nodule is cancer or not can be a long, painful, fearful process. With MyBreathPrint, the doctor will receive results within seconds!
Early Detection
MyBreathPrint’s accuracy, accessibility and lower cost of care can help address the lung cancer screening crisis and drive diagnostic behavior to detect earlier-stage cancers that are more treatable!
Increased survival
Diseases, like cancer, found in their early stages increase survivability, decrease complications and improve long-term health outcomes.
No lab Needed
With our platform approach, there are no fluids to mix, no extra steps to complicate the patient and clinical staff experience.
no extra space
The handheld device is the size of a deck of cards; easy to handle, easy to use with no analytical laboratory equipment or annual maintenance fees.
immediate
After one minute of breathing, results are delivered within moments so you can quickly know and begin discussions with your patient.
accessible
With its size, mobility, connectivity and contribution to a lower cost of care, MyBreathPrint helps break down healthcare accessibility barriers.
Class 2 device
Just one-minute of breathing is required! Completely non-invasive with no needles, no tissue samples, no radiation exposure!
Non-invasive
Accurate
With parts per billion sensitivity, MyBreathPrint can detect VOCs found in breath, and leverage machine learning to generate a BreathPrint.
No Waiting
Knowing whether a nodule is cancer or not can be a long, painful, fearful process. With MyBreathPrint, the doctor will receive results within seconds!
Early Detection
MyBreathPrint’s accuracy, accessibility and lower cost of care can help address the lung cancer screening crisis and drive diagnostic behavior to detect earlier-stage cancers that are more treatable!
Increased survival
Diseases, like cancer, found in their early stages increase survivability, decrease complications and improve long-term health outcomes.
News & Resources
Keep Up to Date with Vocxi Health and the Latest Scientific News
A Breath-through Solution
Learn How and Why Vocxi Health is Transforming the Patient Journey Through Early Disease Detection!
the Breath Solution
The Vocxi Why: to eliminate late-stage diagnosis and save millions of lives, so you know!
science & technology
Learn how with its powerfully sensitive nanosensors, MyBreathPrint connects VOC signals to diseases.
